CuraGen buys back $1.64 million 4% convertibles subordinated notes

New York, July 31 - CuraGen Corp. said it repurchased $1.64 million of its 4% convertible subordinated notes due February 2011 in July.

The company paid $1.39 million for the securities.

As of July 31, it had $12.5 million of the convertibles still outstanding.

So far this year, CuraGen has bought back $6.5 million of the convertibles at an average cost of 80% of par.

CuraGen is a Branford, Conn.-based biopharmaceutical company developing approaches for the treatment of cancer.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.